AKT1 and neoplasm: Moreover, the unphosphorylated JNK and AKT were also downregulated in the HuCCT1 tumor treated with dasatinib at the doses of 0.5 mg/g and 2.0 mg/g by 20–25 and 80–90%, respectively.